≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Bilateral sagittal split ramus osteotomy operation

Endpoint Browser

OPER_BSSRO

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Primary healthcare outpatient: NOMESCO — ^EDC10
  • Operations: NOMESCO codes — ^EDC10

2 out of 7 registries used, show all original rules.

1338

4. Check minimum number of events

None

1338

5. Include endpoints

None

1338

6. Filter based on genotype QC (FinnGen only)

1338

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF7

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 1338 979 359
Unadjusted period prevalence (%) 0.29 0.33 0.16
Median age at first event (years) 38.61 37.59 41.37

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1201
Matched controls
12010
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
SBB10
NOMESCO Finland
Teeth copy
52.4
323.0
779
408
SJD10
NOMESCO Finland
Attachment of arrow to fixed orthodontisk device
168.4
323.0
637
80
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
64.7
323.0
611
189
SAA04
NOMESCO Finland
Special inverstigation of mouth
26.6
323.0
492
305
SJC03
NOMESCO Finland
Positioning and fixed attachment of brackets, extensive
125.1
323.0
396
47
SJC10
NOMESCO Finland
Orthodontic bandage in one tooth
301.5
323.0
544
33
SJD20
NOMESCO Finland
Attachment of modifiable arrow of fixed orthodontisk device
158.4
323.0
587
72
SJD40
NOMESCO Finland
Fixation of ready made palatinal or lingual arrow
103.9
323.0
412
60
SJD30
NOMESCO Finland
Demanding attachment of arrow to fixed orthodontisk device
180.4
323.0
415
35
SJB00
NOMESCO Finland
Fitting of loose orthodontic device with user information
151.9
323.0
520
60
EDC10
NOMESCO Finland
Sagittal osteotomy of ramus of mandible
+∞
323.0
1201
*
SJC50
NOMESCO Finland
Removal of orthodontisk device with at least 7 brackets
166.0
323.0
561
63
SJX10
NOMESCO Finland
Short check-up visit for orthodontisk therapy
66.8
323.0
551
150
K07.13
ICD-10 Finland
Retrognaty, mandibular
876.6
323.0
907
42
K07.23
ICD-10 Finland
Deep bite
75.4
323.0
424
86
EB1MA
NOMESCO Finland
Cephalometry with X-ray
85.8
323.0
442
81
SJD00
NOMESCO Finland
Removal or reattacment of arrow in fixed orthodontisk device
202.4
323.0
688
79
EEC05
NOMESCO Finland
Le Fort I osteotomy
394.3
307.3
297
10
SJC01
NOMESCO Finland
Positioning and fixed attachment of single bracket (Bracket with fixed attachment)
68.8
302.7
345
70
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
22.5
256.9
390
251
SJC40
NOMESCO Finland
Removal of orthodontisk device with at most 6 brackets
65.1
237.0
273
54
SJC02
NOMESCO Finland
Positioning and fixed attachment of brackets
73.9
223.1
252
43
SXC05
NOMESCO Finland
Other oral or dental procedure
15.7
221.2
389
356
SJC00
NOMESCO Finland
Bracket with fixed attachment
245.7
220.8
221
11
SJX11
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment, restricted
57.8
208.2
245
53
K07.24
ICD-10 Finland
Open bite
62.6
204.2
237
47
SJB60
NOMESCO Finland
External device grinding and adaptation
61.9
202.1
235
47
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
8.7
199.3
512
949
K07.1
ICD-10 Finland
Anomalies of jaw-cranial base relationship
294.1
198.3
197
8
K07.10
ICD-10 Finland
Asymmetry of jaw
134.2
182.3
192
17
SJX21
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment
53.1
176.4
211
48
EFB40
NOMESCO Finland
Removal of internal or external fixation device from facial bones
253.9
173.3
174
8
SJX20
NOMESCO Finland
Check-up visit for orthodontisk therapy
43.4
170.2
212
59
K07.20
ICD-10 Finland
Crossbite (anterior)(posterior)
103.4
155.9
169
19
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
12.8
148.7
282
282
SAA03
NOMESCO Finland
Extended examination of mouth
5.0
146.9
827
3669
SAC03
NOMESCO Finland
Separate planning of oral and dental treatment, very demanding
157.9
146.1
152
11
K07.60
ICD-10 Finland
Snapping jaw
10.4
145.3
310
390
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
8.2
134.2
335
543
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
13.8
132.7
240
213
K07.30
ICD-10 Finland
Spacing, abnormal of tooth or teeth
26.6
132.2
186
82
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
9.4
125.1
281
379
SJA04
NOMESCO Finland
Very demanding plan for orthodontic care
348.0
124.9
124
*
K07.14
ICD-10 Finland
Retrognaty, maxillary
120.3
120.7
129
12
SJD50
NOMESCO Finland
Production and attachment of palatinal or lingual arrow
91.9
118.9
131
16
EBB10
NOMESCO Finland
Insertion of dental implant
29.1
111.7
153
60
K07.18
ICD-10 Finland
Another anomaly in the relationship between jaw and skull base
129.4
110.2
117
10
SJB10
NOMESCO Finland
Fitting of loose orthodontic device with user information, demanding
76.6
110.0
124
18
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.0
106.7
642
2694
K07.22
ICD-10 Finland
Anomalies of dental arch relationship
107.8
99.8
108
11
SAC02
NOMESCO Finland
Separate planning of oral and dental treatment, demanding
52.9
96.2
115
24
K07.04
ICD-10 Finland
Macrognathism (mandibular)(maxillary)
245.8
89.8
91
*
K07.11
ICD-10 Finland
Retrognathism (mandibular)(maxillary)
114.5
88.3
95
9
SJF01
NOMESCO Finland
Assessment of need for orthodontic treatment
39.9
83.9
106
29
SJX00
NOMESCO Finland
Reparation of orthodontiskt device by dentist
74.1
73.3
83
12
EDC30
NOMESCO Finland
Genioplasty
+∞
69.4
66
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.9
68.5
667
3574
SPC20
NOMESCO Finland
Attachment of crone of tooth to implant
30.1
68.2
92
33
SJA03
NOMESCO Finland
Demanding plan for orthodontic care
98.5
67.7
74
8
SAC01
NOMESCO Finland
Separate planning of oral and dental treatment, standard
23.9
67.4
97
44
EBA10
NOMESCO Finland
Surgical removal of tooth
3.8
67.0
337
1113
EBB15
NOMESCO Finland
Insertion of dental implant abutment
30.5
65.5
88
31
K07.19
ICD-10 Finland
Anomalies in the relationship between jaw and skull base UNS
662.3
64.5
63
*
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
18.9
63.1
98
56
SJE90
NOMESCO Finland
Finishing face of orthodontick therapy
78.9
59.7
67
9
J01CE02
ATC
phenoxymethylpenicillin; oral
3.0
52.0
994
7396
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
22.1
49.8
73
35
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
4.6
49.5
189
472
K01.0
ICD-10 Finland
Embedded teeth
9.4
48.0
102
117
SXC03
NOMESCO Finland
Other oral or dental procedure
17.7
47.4
75
45
SJA02
NOMESCO Finland
Plan for orthodontic care
75.8
45.3
51
7
K07.12
ICD-10 Finland
Prognathism (mandibular)(maxillary)
162.9
45.1
47
*
SJA01
NOMESCO Finland
Estimation of need for orthodontic care
74.3
44.3
50
7
ZXA10
NOMESCO Finland
Bilateral
3.2
43.5
270
1007
SAA02
NOMESCO Finland
Basic examination of mouth
2.5
41.4
930
6951
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
12.0
40.4
75
66
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
9.2
38.8
83
96
K07.27
ICD-10 Finland
Anomalies of dental arch relationship
29.5
38.0
51
18
K00.00
ICD-10 Finland
Hypodontia
14.6
37.7
64
46
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
9.6
35.2
73
80
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
6.2
33.7
94
162
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
26.5
33.4
46
18
K07.0
ICD-10 Finland
Major anomalies of jaw size
335.9
33.0
33
*
OIKK
NOMESCO Finland
NA
10.5
31.9
63
63
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
4.6
31.7
115
269
SPB10
NOMESCO Finland
Production of temporary crone to tooth
26.2
31.2
43
17
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
13.8
30.7
53
40
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
5.9
30.0
87
158
K07.9
ICD-10 Finland
Dentofacial anomaly, unspecified
109.5
29.8
32
*
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
2.7
29.6
229
961
K07.01
ICD-10 Finland
Hyperplasia, hypoplasia mandibular
298.8
28.9
29
*
EB1WA
NOMESCO Finland
NA
21.7
28.8
42
20
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
12.9
28.8
51
41
EFB50
NOMESCO Finland
Orthodontic procedure connected with ortognathic surgery
148.4
27.7
29
*
SDA02
NOMESCO Finland
Parodonthologic therapy
2.0
27.6
475
2920
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
8.2
27.4
62
79
K07.69
ICD-10 Finland
Dislocation of the jaw joint UNS
7.6
26.5
63
87
SPA20
NOMESCO Finland
Selection and insertion of implantdistans
26.9
25.0
34
13
ECB40
NOMESCO Finland
Surgical treatment of fracture of alveolus
14.6
24.5
41
29
SPB20
NOMESCO Finland
Temporary bridge between two or more teeth
26.0
24.0
33
13
Z96.5
ICD-10 Finland
Presence of tooth-root and mandibular implants
34.1
23.4
30
9
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
2.0
23.2
369
2164
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.1
23.0
94
246
K07.21
ICD-10 Finland
Anomalies of dental arch relationship
66.3
22.9
26
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
22.8
340
1938
EEC02
NOMESCO Finland
Rapid expansion of maxilla
85.1
22.7
25
*
EDW99
NOMESCO Finland
Other operation on mandible
44.2
21.5
26
6
SAA01
NOMESCO Finland
Simple examination of mouth
1.9
21.4
930
7670
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
12.2
21.1
38
32
K07.4
ICD-10 Finland
Malocclusion, unspecified
5.9
20.0
56
98
SPAT1324
SPAT
Screening procedure
1.9
19.4
350
2127
SPC40
NOMESCO Finland
Preparation of first or second intermediate attachment tooth for bridge
17.1
19.2
30
18
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
11.6
19.0
35
31
EBA12
NOMESCO Finland
Complicated surgical removal of tooth
3.8
18.1
77
210
K07.00
ICD-10 Finland
Macrognatia (hyperplasia) of the upper jaw
67.6
17.8
20
*
SPA41
NOMESCO Finland
Precision impression for fixed dental prosthesis
9.1
17.7
37
42
EG1CG
NOMESCO Finland
Extensive MRI examination of mandipular joint with high intensity magnet
13.3
17.5
30
23
K07.03
ICD-10 Finland
Micrognatia (hypoplasia) of the upper jaw
50.8
17.0
20
*
EGA00
NOMESCO Finland
Arthroscopy of mandibular joint
26.0
16.9
23
9
R06.5
ICD-10 Finland
Mouth breathing
2.6
16.5
130
543
K07.09
ICD-10 Finland
Anomaly in the size of the jaws UNS
172.3
16.5
17
*
SPC08
NOMESCO Finland
Implant crown
24.9
16.0
22
9
EB1BD
NOMESCO Finland
Extensive cone beam CT of teeth and jaws (two quarters)
60.8
15.8
18
*
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
2.3
15.7
156
735
K01.17
ICD-10 Finland
Retained molar with obstruction in the lower jaw
4.2
15.7
60
149
ECA70
NOMESCO Finland
Regenerative parodontal operation or gingiva and alveolus transplantation
23.7
15.1
21
9
EBA00
NOMESCO Finland
Extraction of tooth
1.7
14.9
402
2735
EEC00
NOMESCO Finland
Segmental osteotomy of maxilla
+∞
14.6
14
*
M01AE03
ATC
ketoprofen; systemic, rectal
1.7
14.6
408
2805
EAB10
NOMESCO Finland
Excision and repair of frenum of lip
27.5
14.3
19
7
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
14.2
396
2714
K07.62
ICD-10 Finland
Habitual dislocation of the jaw joint
7.3
13.6
32
45
EB1TW
NOMESCO Finland
3D modelling of dentition
+∞
13.6
13
*
K07.29
ICD-10 Finland
Anomaly in the relationship between the tooth arches UNS
34.4
13.5
17
5
EBA40
NOMESCO Finland
Excision of apex of root of tooth
7.4
13.3
31
43
TEG00
NOMESCO Finland
Punction of mandibular joint
28.7
13.0
17
6
J01FF01
ATC
clindamycin; systemic
1.7
12.9
318
2092
M01AE01
ATC
ibuprofen; systemic, rectal
2.2
12.7
1115
10287
EMAK
NOMESCO Finland
NA
3.2
12.7
66
213
EG1AA
NOMESCO Finland
Mandibular joint X-ray examination
12.4
12.6
22
18
N02BE01
ATC
paracetamol; systemic, rectal
1.7
12.6
985
8710
SJD60
NOMESCO Finland
NA
+∞
12.5
12
*
K07.05
ICD-10 Finland
Micrognatia (hypoplasia) of both jaws
+∞
12.5
12
*
XX2XX
NOMESCO Finland
NA
+∞
12.5
12
*
EDC45
NOMESCO Finland
Reconstruction of mandible using bone graft
+∞
12.5
12
*
WX720
NOMESCO Finland
Own respiration
3.4
12.4
59
178
N03AX16
ATC
pregabalin; oral
1.7
11.6
248
1558
SPC25
NOMESCO Finland
Other demanding attachment of crone of tooth
23.1
11.6
16
7
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.6
11.6
462
3436
G47.3
ICD-10 Finland
Sleep apnoea
1.8
11.5
232
1428
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.6
11.5
337
2313
Z47.0
ICD-10 Finland
Follow-up care involving removal of fracture plate and other internal fixation device
9.4
11.5
23
25
K07.2
ICD-10 Finland
Anomalies of dental arch relationship
+∞
11.5
11
*
K06.00
ICD-10 Finland
Local gingivore traction
4.6
11.3
38
84
K07.26
ICD-10 Finland
Anomalies of dental arch relationship
35.4
11.3
14
*
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
20.2
11.1
16
8
WX704
NOMESCO Finland
Intubation
2.4
10.6
92
404
SPAT1263
SPAT
Sampling
1.5
10.4
477
3633
SXB10
NOMESCO Finland
Removal of attachments and rails from moth
16.2
10.4
16
10
K07.33
ICD-10 Finland
Crowding of tooth or teeth
32.8
10.3
13
*
ECB05
NOMESCO Finland
Mucogingival repair
10.7
10.3
19
18
K07.61
ICD-10 Finland
Cracking jaw joint
3.4
10.3
48
144
EGC10
NOMESCO Finland
Arthroplasty of mandibular joint without graft
40.4
10.0
12
*
G50.8
ICD-10 Finland
Other disorders of trigeminal nerve
16.9
9.9
15
9
SPC09
NOMESCO Finland
Implant crown, demanding
55.4
9.7
11
*
YEA05
NOMESCO Finland
Excision of gingival or connective tissue for transplantation
55.4
9.7
11
*
ECB20
NOMESCO Finland
Oral alveoplasty
11.5
9.6
17
15
ECU00
NOMESCO Finland
Removal of implant or external fixation device from alveoli
30.3
9.4
12
*
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
9.0
415
3140
EB1AD
NOMESCO Finland
Cone beam CT of teeth and jaws (one quarter)
10.1
9.0
17
17
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
3.8
9.0
36
96
XX3DW
NOMESCO Finland
Time consuming IT work
2.1
8.8
100
499
HAMTE
NOMESCO Finland
NA
6.0
8.8
23
39
SPA02
NOMESCO Finland
Preparation for dental prosthetics
4.5
8.6
29
66
TEG10
NOMESCO Finland
Injection of diagnostic or therapeutic substance into mandibular joint
20.2
8.5
12
6
EGC30
NOMESCO Finland
Prosthetic replacement of mandibular joint
90.7
8.4
9
*
SPC50
NOMESCO Finland
Pivot column
90.7
8.4
9
*
Q37.1
ICD-10 Finland
Cleft hard palate with unilateral cleft lip
90.7
8.4
9
*
K07.68
ICD-10 Finland
Other disorders of the jaw joint
6.8
8.4
20
30
F45.8
ICD-10 Finland
Other somatoform disorders
1.9
8.3
118
643
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
8.1
512
4102
EB1S1
NOMESCO Finland
Photography of teeth
33.6
8.1
10
*
P01AB01
ATC
metronidazole; oral, rectal
1.4
7.9
454
3566
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.2
7.7
74
344
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
2.0
7.7
102
541
SCD01
NOMESCO Finland
Simple removal of tooth plaque or tartar
5.3
7.7
22
42
EEW99
NOMESCO Finland
Other operation on maxilla
80.6
7.4
8
*
EEC45
NOMESCO Finland
Reconstruction of maxilla using bone graft
80.6
7.4
8
*
ECB10
NOMESCO Finland
Reconstruction of gingiva
13.4
7.4
12
9
G50.1
ICD-10 Finland
Atypical facial pain
3.7
7.4
30
82
A02BC05
ATC
esomeprazole; systemic
1.4
7.3
405
3148
A02BC03
ATC
lansoprazole; oral
1.5
7.3
271
1943
M79.1
ICD-10 Finland
Myalgia
1.7
7.3
153
950
K05.30
ICD-10 Finland
Periodontitis complex
1.8
7.3
116
661
EDC99
NOMESCO Finland
Other reconstructive operations on mandible
30.2
7.2
9
*
Z50.1
ICD-10 Finland
Other physical therapy
2.5
7.1
54
225
Z01.2
ICD-10 Finland
Dental examination
1.4
7.0
483
3903
SPF40
NOMESCO Finland
Removal and reattachment with cement of tooth crone or short bridge
4.0
7.0
26
66
WX725
NOMESCO Finland
Noninvasive ventilation
2.4
6.7
54
232
XF400
NOMESCO Finland
ECG with 12 standard connections
0.4
6.6
35
768
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
7.9
6.6
14
18
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
6.5
214
1490
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.4
6.4
343
2636
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.7
6.4
125
761
K07
ICD-10 Finland
Dentofacial anomalies [including malocclusion]
6.6
6.3
15
23
XX2XT
NOMESCO Finland
Other injection with other radiological guidance
6.6
6.3
15
23
M03BX02
ATC
tizanidine; oral
1.4
6.3
727
6359
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.4
6.3
292
2187
SCC01
NOMESCO Finland
Simple fluorination of mouth or other corresponding procedure
2.5
6.2
45
184
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.9
6.1
91
506
ED1AA
NOMESCO Finland
Mandipular X-ray examination
6.1
6.0
15
25

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
573
4256
1.61
15.45
3.2
3.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
640
5077
1.50
11.74
3.8
3.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
659
5405
1.43
9.38
3.1
3.0
estimate
0.0
0.0
0.50
136
1011
(3041096) Erythrocytes [Presence] in Urine by Automated
417
3170
1.46
8.81
2.6
2.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
658
5468
1.40
8.31
3.2
3.0
estimate
0.0
0.0
1.06
134
997
(3021601) Nitrite [Presence] in Urine by Test strip
652
5422
1.39
8.14
4.3
4.1
estimate
0.0
0.0
0.41
138
1045
(3030981) Hyaline casts [#/volume] in Urine by Automated count
85
436
2.01
8.08
1.8
2.5
e6/l
0.1
0.1
0.17
80
412
(3029937) Albumin [Presence] in Urine by Test strip
375
2834
1.45
8.04
3.4
3.3
estimate
0.0
0.0
1.28
138
1027
(1761482) Bacteria [#/volume] in Urine by Culture
45
180
2.55
7.72
3.7
3.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
899
7975
1.39
7.12
4.0
3.7
mm/h
8.1
9.6
5.47
856
7509
(3019150) Specific gravity of Urine by Refractometry
300
2290
1.40
5.85
3.4
3.2
kg/l
1.0
1.0
0.13
42
310
(40760892) CBC W Ordered Manual Differential panel - Blood
354
2789
1.37
5.67
4.0
4.3
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
29
112
2.62
5.41
2.5
1.9
nmol/l
22.5
20.4
0.53
29
106
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
245
1831
1.41
5.36
1.5
1.6
pmol/l
44843501.6
38122318.2
0.07
223
1608
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
53
966
0.53
5.01
2.6
2.4
u/l
30.8
91.0
0.64
44
820
(3033658) Prothrombin time (PT) actual/Normal
186
2518
0.70
4.95
3.2
3.4
%
97.2
97.0
0.04
178
2440
(40761535) Cells panel - Urine sediment
109
718
1.56
4.48
3.3
3.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1111
10488
1.35
4.07
4.7
4.7
mu/l
1.7
2.1
0.93
1060
9924
(3047181) Lactate [Moles/volume] in Blood
48
262
1.86
3.94
2.2
10.0
mmol/l
1.3
1.2
0.17
43
225
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
98
653
1.54
3.85
1.4
1.5
—
—
—
0
0
(44813793)
23
96
2.42
3.74
1.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
90
593
1.56
3.73
1.4
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1251
12087
1.54
3.72
10.2
9.9
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
30
142
2.14
3.66
2.4
2.6
mmol/l
1.5
1.3
0.66
30
136
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
72
1110
0.63
3.65
2.9
3.6
%
30.3
31.4
0.49
56
837
(3023103) Potassium [Moles/volume] in Serum or Plasma
1168
11158
1.37
3.58
8.9
10.9
mmol/l
3.9
3.9
0.30
1146
10871
(3017181) Myelocytes/100 leukocytes in Blood
119
850
1.44
3.36
3.5
4.2
%
1.0
1.0
0.08
26
220
(3021387) Prolactin [Units/volume] in Serum or Plasma
101
700
1.48
3.33
1.6
1.6
mu/l
303.3
302.6
0.01
92
629
(3025159) Blasts/100 leukocytes in Blood
109
768
1.46
3.31
3.5
4.3
%
0.0
0.6
0.63
14
169
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
97
1376
0.68
3.30
2.1
2.5
e6/l
2.5
3.4
0.75
60
710
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
964
9029
1.24
3.14
4.3
4.1
pmol/l
14.4
14.4
0.12
914
8466
(3019550) Sodium [Moles/volume] in Serum or Plasma
1160
11120
1.32
3.06
8.8
10.8
mmol/l
139.9
139.7
2.86
1139
10852
(3021440) Promyelocytes/100 leukocytes in Blood
112
807
1.42
3.03
3.6
4.3
%
0.2
0.2
0.11
22
201
(3002179) Metamyelocytes/100 leukocytes in Blood
109
786
1.42
2.95
3.5
4.0
%
1.3
0.7
0.58
14
161
(3017569) Oxygen content in Arterial blood
10
30
3.35
2.91
2.3
4.5
—
—
—
0
0
(4035726)
53
827
0.63
2.87
1.3
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
153
1173
1.34
2.86
1.7
1.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1092
10409
1.27
2.84
12.2
13.1
g/l
333.7
333.1
1.49
1085
10339
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
368
3155
1.23
2.82
2.2
2.5
u/l
53.7
55.4
0.55
350
2955
(3044242) Glucose [Moles/volume] in Arterial blood
11
36
3.07
2.81
2.5
3.8
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
19
392
0.48
2.73
4.0
10.1
mmol/l
23.4
24.3
0.68
14
378
(3017446) Testosterone [Moles/volume] in Serum or Plasma
99
713
1.42
2.71
2.5
2.2
nmol/l
12.2
12.5
0.16
94
651
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1177
11342
1.31
2.70
9.7
10.6
mg/l
16.2
20.2
4.63
910
8716
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
853
7947
1.20
2.67
5.8
6.9
u/l
70.7
74.6
4.05
821
7525
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
323
2751
1.23
2.62
1.5
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
12
287
0.41
2.55
2.3
3.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
87
620
1.43
2.54
1.3
1.3
miu/ml
231.6
217.4
0.15
46
317
(3008152) Bicarbonate [Moles/volume] in Arterial blood
65
442
1.49
2.42
3.8
10.0
mmol/l
23.9
24.6
0.69
60
409
(3009214) Lutropin [Units/volume] in Serum or Plasma
66
451
1.49
2.40
1.2
1.3
u/l
11.4
10.6
0.17
54
371
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
22
412
0.53
2.39
1.5
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
224
2676
0.80
2.32
4.0
6.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
39
619
0.62
2.32
3.9
8.4
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
89
649
1.40
2.31
1.2
1.1
titre
145.0
169.2
—
5
12
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
217
1800
1.25
2.24
1.5
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
16
73
2.21
2.21
1.5
2.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
78
1067
0.71
2.21
3.4
5.8
mmol/l
1.0
1.0
1.16
72
1008
(3007461) Platelets [#/volume] in Blood
1308
12880
1.69
2.19
15.1
15.7
e9/l
259.0
262.0
1.11
1300
12628
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
369
3236
1.19
2.18
2.4
2.7
ng/l
17.2
38.9
2.26
183
1674
(3026361) Erythrocytes [#/volume] in Blood
1309
12895
1.70
2.15
15.1
15.7
e12/l
4.6
4.6
0.40
1300
12632
(3027273) Bicarbonate [Moles/volume] in Venous blood
49
323
1.54
2.14
2.6
3.2
mmol/l
25.3
25.4
0.17
49
311
(3014051) Protein [Presence] in Urine by Test strip
10
236
0.42
2.10
2.7
1.7
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
31
183
1.71
2.09
2.0
3.6
mg/l
20.2
25.0
0.45
19
113
(3010813) Leukocytes [#/volume] in Blood
1309
12899
1.68
2.09
15.2
15.7
e9/l
6.4
6.7
2.88
1298
12628
(3035285) Chloride [Moles/volume] in Venous blood
16
75
2.15
2.09
1.5
2.3
mmol/l
105.4
105.4
0.01
16
75
(3041354) Potassium [Moles/volume] in Venous blood
16
75
2.15
2.09
1.5
2.3
mmol/l
3.9
4.0
0.29
16
75
(3051101) Glucose [Moles/volume] in Cord blood
5
10
5.01
2.07
10.2
4.5
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
57
0.00
2.05
0.0
2.0
—
147.4
—
0
52
(3037467) Urinalysis macro (dipstick) panel - Urine
791
7412
1.16
2.01
3.8
3.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
76
557
1.39
1.95
1.8
2.1
ug/l
4.2
7.4
2.02
71
512
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
132
1050
1.29
1.95
5.1
5.0
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
43
282
1.54
1.94
1.4
1.4
u/l
20.6
24.4
0.39
33
241
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
52
357
1.48
1.90
1.8
1.7
nmol/l
36.2
39.3
0.49
52
350
(3027456) Digoxin [Moles/volume] in Serum or Plasma
0
50
0.00
1.89
0.0
2.5
—
0.9
—
0
37
(3026389) Candida sp identified in Specimen by Organism specific culture
24
136
1.78
1.88
1.5
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
337
2977
1.18
1.81
1.7
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
52
734
0.70
1.81
3.9
4.4
ug/l
30.4
20.6
0.18
40
566
(3023323) Follitropin [Units/volume] in Serum or Plasma
125
999
1.28
1.80
1.2
1.4
iu/l
29.0
27.7
0.16
111
847
(1761868) Lipid panel - Serum or Plasma
532
4872
1.15
1.78
2.6
2.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
595
5494
1.15
1.77
2.6
2.7
ug/l
75.5
90.8
2.94
571
5198
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
49
339
1.46
1.75
1.1
1.1
u/ml
0.4
1.7
1.60
21
136
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
21
358
0.58
1.72
2.0
3.3
mmol/l
24.5
24.1
0.30
14
328
(3003888) Timothy IgE Ab [Units/volume] in Serum
45
309
1.47
1.67
1.0
1.1
u/ml
4.0
6.3
0.41
21
159
(3044889) 12 lead EKG panel
762
7174
1.14
1.67
2.9
2.9
—
—
—
0
0
(3013512) EKG study
270
2359
1.18
1.65
2.5
2.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
66
488
1.37
1.65
1.9
1.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
239
2742
0.84
1.61
1.8
1.6
mmol/l
1.4
1.4
0.19
203
2380
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
969
9297
1.15
1.55
3.4
3.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
30
192
1.58
1.55
1.8
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
180
2110
0.83
1.54
3.4
4.0
—
—
—
0
0
(4268621)
6
142
0.42
1.52
2.0
2.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
609
5678
1.13
1.49
3.1
4.3
mmol/l
6.2
6.4
2.10
552
5217
(3026008) Bacteria identified in Urine by Culture
295
2619
1.16
1.48
2.3
2.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
240
2098
1.18
1.46
1.3
1.3
u/ml
9.1
9.5
0.04
127
899
(42870588) Differential panel, method unspecified - Blood
307
3427
0.86
1.45
5.2
5.8
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
63
474
1.35
1.44
1.8
2.6
ng/l
68.8
119.4
2.17
54
413
(3023430) Cat dander IgE Ab [Units/volume] in Serum
35
237
1.49
1.43
1.1
1.1
u/ml
1.7
5.7
2.34
19
97
(3000330) Specific gravity of Urine by Test strip
57
424
1.36
1.40
4.0
2.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
89
708
1.28
1.38
1.5
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
105
853
1.25
1.37
2.4
2.2
u/l
5213.0
4683.9
0.07
48
336
(3036481) Cortisol [Moles/volume] in Serum or Plasma
126
1046
1.23
1.35
2.0
2.0
nmol/l
365.3
371.7
0.12
114
972
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
39
0.00
1.34
0.0
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
39
0.00
1.34
0.0
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
39
0.00
1.34
0.0
1.6
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
18
105
1.72
1.33
1.7
1.7
%
26.2
57.9
—
9
68
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
52
386
1.36
1.31
1.0
1.1
u/ml
4.3
4.3
—
9
62
(3023199) Leukocytes [#/volume] in Pleural fluid
0
41
0.00
1.31
0.0
1.4
—
1878.4
—
0
25
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
41
0.00
1.31
0.0
2.6
—
74002.2
—
0
6
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
284
2538
1.15
1.30
1.6
1.7
mg/l
0.7
0.9
1.27
204
1863
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
30
437
0.68
1.30
1.6
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
36
506
0.70
1.29
1.4
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
55
414
1.34
1.28
2.1
2.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1104
10740
1.16
1.28
3.4
3.4
mmol/l
1.3
1.3
0.23
1062
10203
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
97
1183
0.81
1.26
2.2
2.6
umol/l
6.8
6.8
0.01
84
1011
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
44
595
0.73
1.25
2.2
3.8
ng/l
72.6
78.1
0.30
38
540
(3020650) Glucose [Presence] in Urine
8
36
2.23
1.24
1.1
1.5
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
41
296
1.40
1.23
1.1
1.1
u/ml
0.7
2.9
1.79
17
75
(3008401) Mugwort IgE Ab [Units/volume] in Serum
41
296
1.40
1.23
1.0
1.1
u/ml
0.4
1.9
1.39
13
118
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
107
883
1.23
1.23
2.3
2.7
—
—
—
0
0
(4034850)
48
357
1.36
1.21
5.2
7.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
73
577
1.28
1.21
1.8
1.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
222
2504
0.86
1.21
2.1
2.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
353
3218
1.13
1.21
5.6
5.7
inr
1.1
1.1
0.11
139
1057
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
68
534
1.29
1.19
1.5
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
86
696
1.25
1.18
3.1
3.2
mmol/l
1.2
1.2
0.09
74
608
(3018405) Lactate [Moles/volume] in Arterial blood
35
248
1.42
1.17
2.6
4.7
mmol/l
1.4
1.4
0.12
35
242
(3025941) Bacteria identified in Stool by Culture
86
697
1.25
1.17
1.2
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
14
79
1.78
1.17
1.7
1.4
e6/l
2465.4
9224.9
—
9
54
(3027008) Opiates [Presence] in Urine
90
734
1.24
1.16
1.6
1.9
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
34
0.00
1.16
0.0
1.6
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
8
39
2.06
1.15
1.1
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
72
1.81
1.15
1.0
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
263
2360
1.14
1.14
2.1
2.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
90
736
1.24
1.14
1.6
1.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
184
1611
1.16
1.12
2.1
2.4
ug/g
95.5
104.0
0.25
149
1287
(40768793) Breast Pathology biopsy report
19
294
0.64
1.12
1.5
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
102
847
1.22
1.12
3.4
3.5
pmol/l
4.5
4.6
0.97
94
764
(3000764) Benzodiazepines [Presence] in Urine
89
729
1.24
1.11
1.6
1.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
514
4810
1.11
1.11
7.9
8.2
e9/l
0.0
0.0
1.05
471
3953
(40768443) Skin Pathology biopsy report
51
390
1.32
1.10
1.5
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
9
163
0.55
1.08
2.2
1.7
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
36
261
1.39
1.08
1.2
1.1
u/ml
6.2
4.1
0.22
21
99
(3012516) Albumin [Mass/volume] in Urine
207
2326
0.87
1.08
2.5
3.3
mg/l
734.5
367.8
0.33
126
1479
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
19
290
0.65
1.07
1.8
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
166
1451
1.16
1.05
3.7
3.3
%
20.4
21.3
0.28
62
535
(3024891) Influenza virus A+B Ag [Presence] in Specimen
25
359
0.69
1.04
1.1
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
17
264
0.64
1.04
1.3
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
195
1730
1.15
1.01
2.0
2.7
ng/l
431.1
651.0
0.88
158
1399
(3003327) Ova and parasites identified in Stool by Light microscopy
56
440
1.28
1.01
1.5
1.8
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1017
9887
1.12
1.01
11.2
12.8
%
13.3
13.5
1.64
994
9701
(1002224) Polysomnography panel
51
650
0.78
1.00
1.1
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
158
0.57
0.98
1.1
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
158
0.57
0.98
1.1
1.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
23
2.18
0.98
2.2
3.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
23
2.18
0.98
2.2
3.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
87
723
1.22
0.98
1.5
1.9
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
29
0.00
0.97
0.0
2.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
21
140
1.51
0.97
1.0
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
116
1351
0.85
0.97
1.2
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
30
0.00
0.97
0.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
125
1076
1.18
0.96
1.2
1.2
iu/ml
74.1
145.2
2.50
49
436
(3030467) Casts [#/volume] in Urine by Automated count
225
2493
0.88
0.96
2.2
2.6
e6/l
0.2
0.4
1.15
180
1841
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
29
208
1.40
0.95
1.6
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
155
1758
0.87
0.93
1.7
1.8
%
1.3
1.4
2.23
142
1595
(3044640) Blood type and Crossmatch panel - Blood
349
3227
1.11
0.93
1.9
2.0
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
54
428
1.27
0.93
2.5
3.1
g/l
138.2
132.2
1.32
54
419
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
234
2119
1.13
0.90
2.1
2.0
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
45
351
1.29
0.88
1.2
1.7
g/l
0.2
0.2
0.05
39
333
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
128
1465
0.86
0.88
1.9
2.3
e6/l
1.3
1.0
0.27
90
796
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1223
12053
1.17
0.88
8.8
8.8
u/l
26.3
26.8
0.41
1197
11755
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
17
111
1.54
0.88
1.4
1.3
u/ml
0.3
0.5
0.49
12
40
(3009508) Creatinine [Moles/volume] in Urine
251
2747
0.89
0.87
2.3
3.1
mmol/l
8.1
8.1
0.01
231
2366
(3000850) Epithelial cells [#/volume] in Urine
208
1875
1.13
0.87
2.0
2.3
e6/l
6.1
7.5
0.49
183
1650
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1136
11144
1.13
0.85
3.7
3.7
mmol/l
1.5
1.5
1.91
1089
10602
(21494755) Public health laboratory ask at order entry panel
202
1820
1.13
0.85
1.4
1.3
—
—
—
0
0
(4010399)
79
662
1.21
0.84
1.4
1.4
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
8
45
1.78
0.84
1.6
2.1
—
17.6
—
0
5
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
45
354
1.28
0.83
1.6
1.6
iu/ml
0.0
0.2
—
7
57
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
113
0.53
0.83
1.5
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
140
0.57
0.83
1.1
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
135
1531
0.87
0.83
1.8
1.6
—
—
—
0
0
(4198724)
11
65
1.70
0.82
1.9
1.9
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
47
1.71
0.80
1.0
1.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
462
4361
1.09
0.80
3.8
6.2
mmol/l
1.2
1.2
0.16
393
3697
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
16
235
0.68
0.79
1.9
1.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
25
0.00
0.79
0.0
1.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
718
6908
1.08
0.78
3.6
3.6
e6/l
1253.3
350.3
0.62
12
70
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1148
11282
1.12
0.78
3.9
4.0
mmol/l
3.0
2.9
1.66
1098
10716
(3012501) Base excess in Blood by calculation
25
182
1.38
0.78
2.1
2.5
mmol/l
2.2
2.4
0.18
18
117
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
27
0.00
0.77
0.0
2.0
—
2037.1
—
0
17
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
47
582
0.80
0.77
1.4
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
187
1690
1.12
0.76
1.6
1.6
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
188
1701
1.12
0.75
1.4
1.4
titre
414.1
531.1
0.82
37
335
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1137
11173
1.12
0.75
3.8
3.8
mmol/l
4.9
4.8
1.54
1088
10686
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
13
83
1.57
0.75
1.2
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
27
201
1.35
0.74
1.2
1.4
mmol/l
7.0
7.1
0.04
17
143
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
24
2.09
0.74
1.6
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
45
361
1.26
0.74
2.1
1.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
199
1810
1.12
0.73
4.3
3.6
ug/l
1.7
1.8
0.13
187
1668
(3000093) Morphology [Interpretation] in Blood Narrative
9
55
1.64
0.73
1.1
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
56
461
1.22
0.73
2.7
7.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
8
135
0.59
0.73
2.3
3.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
9
56
1.61
0.72
1.0
1.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
56
1.61
0.72
2.1
3.4
u/ml
894.4
597.2
—
9
56
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
60
1.67
0.72
1.1
1.1
miu/ml
1918.9
1522.9
—
10
60
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
41
327
1.26
0.71
1.9
1.8
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
24
177
1.36
0.71
1.8
2.5
mmol/l
23.6
24.9
1.59
19
164
(3024928) Oxygen saturation in Venous blood
10
158
0.63
0.70
1.5
3.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
7
41
1.71
0.70
1.9
2.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
9
144
0.62
0.69
1.6
1.5
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
27
1.85
0.68
1.0
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
68
576
1.19
0.68
1.6
2.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
48
583
0.82
0.68
1.4
1.4
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
45
366
1.24
0.67
1.2
1.7
g/l
1.2
1.2
0.09
39
347
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
92
0.54
0.67
1.4
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
237
0.71
0.66
1.8
1.6
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
5
28
1.79
0.66
1.0
1.1
u/ml
3.4
0.4
—
5
22
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
248
0.72
0.65
1.0
1.7
g/l
2.6
3.0
1.72
13
204
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
12
78
1.54
0.65
2.2
2.3
%
20.0
13.5
—
6
37
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
11
70
1.58
0.65
2.4
2.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
29
224
1.30
0.65
1.0
1.0
u/ml
2.2
2.1
0.05
22
113
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
16
223
0.71
0.63
1.7
2.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
25
190
1.32
0.63
1.2
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
15
211
0.71
0.62
1.1
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
17
121
1.41
0.62
1.2
1.5
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
20
0.00
0.60
0.0
8.8
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
49
585
0.83
0.60
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
49
584
0.83
0.59
1.4
1.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
22
0.00
0.59
0.0
2.7
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
22
0.00
0.59
0.0
1.8
—
10.8
—
0
17
(3001556) Androgen free Index in Serum or Plasma
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
22
166
1.33
0.58
1.4
1.6
mmol/l
7.2
7.4
0.14
16
98
(3013139) Helicobacter pylori Ag [Presence] in Stool
87
764
1.15
0.58
1.2
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
227
2441
0.92
0.58
3.3
3.9
mg/mmol
4.6
10.0
1.71
147
1548
(3002523) Influenza virus A Ag [Presence] in Specimen
23
298
0.77
0.58
1.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
23
298
0.77
0.58
1.2
1.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
588
5663
1.07
0.58
5.2
6.1
e9/l
0.2
0.2
0.11
558
5091
(3047007) Chlamydophila sp Ab [Presence] in Serum
16
219
0.73
0.58
1.1
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
28
353
0.79
0.57
2.0
2.1
iu/l
4.9
4.7
—
9
142
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
88
0.57
0.56
1.2
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
41
493
0.83
0.55
1.4
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
40
482
0.82
0.55
1.4
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
372
3532
1.07
0.55
1.6
1.6
—
—
—
0
0
(3019225) pH of Specimen
70
803
0.86
0.55
1.9
3.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
115
1035
1.12
0.54
1.5
1.7
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
12
82
1.47
0.54
1.8
1.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
292
3097
0.93
0.54
2.3
3.2
mmol/l
2.4
2.4
0.24
276
2817
(3007164) IgA [Mass/volume] in Serum or Plasma
234
2504
0.92
0.54
1.4
1.4
g/l
2.2
2.3
0.44
179
1634
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
30
240
1.26
0.54
1.6
1.7
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
261
0.76
0.54
1.0
1.7
g/l
3.8
3.9
0.14
13
199
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
261
0.76
0.54
1.0
1.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
261
0.76
0.54
1.0
1.7
g/l
6.5
7.3
1.18
14
213
(3005033) Fetal Nuchal fold Thickness US
40
479
0.83
0.52
1.4
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
96
0.62
0.52
1.2
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
309
2921
1.08
0.52
1.3
1.3
u/ml
1.2
1.4
0.24
121
831
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
169
0.71
0.52
3.9
3.1
—
2071.5
—
0
14
(3016879) Cocaine [Presence] in Urine
77
678
1.14
0.51
1.6
2.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
136
0.66
0.51
2.3
1.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
370
3882
0.94
0.51
3.2
5.5
mmol/l
1.2
1.2
0.28
335
3571
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
145
0.69
0.50
1.5
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1077
10608
1.08
0.50
3.6
3.7
mmol/l
5.6
5.7
8.68
1037
9972
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
236
2211
1.08
0.50
1.3
1.3
iu/ml
25.5
25.8
0.02
82
696
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
12
84
1.43
0.49
1.5
1.4
umol/l
9.4
10.3
0.35
12
78
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
45
1.56
0.49
1.6
1.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
75
845
0.88
0.47
2.4
2.7
g/l
9.4
10.4
1.55
69
780
(3019069) Monocytes/100 leukocytes in Blood
495
5135
0.94
0.47
5.5
6.0
%
8.4
8.1
1.25
480
4876
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
42
356
1.19
0.46
1.2
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
533
5149
1.06
0.46
4.3
5.8
umol/l
9.6
10.3
1.51
509
4877
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
15
198
0.75
0.45
1.1
1.1
iu/ml
11.8
2529.1
—
5
52
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
96
1061
0.90
0.45
1.5
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1068
10530
1.07
0.45
7.8
9.1
ml/min/173m2
90.4
90.8
0.27
912
8630
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
400
3837
1.06
0.44
3.4
3.2
u/l
30.2
30.1
0.02
380
3660
(4094501)
33
275
1.21
0.43
1.1
1.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
583
5654
1.06
0.43
5.2
5.8
e9/l
1.9
2.0
0.85
553
5110
(3019309) Folate [Moles/volume] in Red Blood Cells
139
1283
1.09
0.43
1.5
1.6
nmol/l
1274.2
1178.3
0.75
117
1016
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
40
468
0.85
0.43
1.6
3.1
mmol/l
0.9
1.6
1.27
25
346
(3022145) Colonoscopy Study observation
124
1139
1.10
0.43
1.2
1.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
493
5100
0.95
0.42
5.2
5.8
%
2.9
2.8
0.73
478
4806
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
32
1.56
0.42
1.0
2.1
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
8
57
1.41
0.42
1.3
1.7
nmol/l
1.1
2.4
—
8
44
(3044009) aPTT.lupus sensitive (LA screen)
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
15
0.00
0.41
0.0
3.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
15
0.00
0.41
0.0
10.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
15
0.00
0.41
0.0
4.2
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
8.3
—
0.4
—
0
15
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
2.3
—
1.3
—
0
10
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.6
—
790003.8
—
0
10
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
54
614
0.87
0.41
1.5
1.8
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
8
59
1.36
0.41
1.3
1.7
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
163
1521
1.08
0.40
1.8
1.9
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
34
1.47
0.40
2.2
1.4
ug/l
8.0
8.3
—
5
34
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
48
418
1.15
0.40
1.4
1.5
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
18
0.00
0.40
0.0
2.3
—
0.9
—
0
18
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
101
0.69
0.39
1.0
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
103
0.68
0.39
1.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
19
0.00
0.39
0.0
9.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
19
0.00
0.39
0.0
2.6
—
—
—
0
0
(4015189)
0
19
0.00
0.39
0.0
4.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
104
954
1.10
0.38
3.2
3.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
132
1421
0.92
0.38
2.5
3.4
mmol/l
0.8
0.8
0.42
120
1346
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
136
1461
0.92
0.37
2.1
2.5
mmol/l
2.4
2.4
0.23
130
1288
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
331
3448
0.95
0.37
1.6
1.7
pmol/l
100.8
98.1
0.50
178
1868
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
16
125
1.28
0.37
1.3
1.4
nmol/l
—
—
—
0
0
(3020891) Body temperature
33
281
1.18
0.36
3.6
5.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
9
71
1.27
0.36
6.8
6.9
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
22
180
1.23
0.36
1.1
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
27
226
1.20
0.36
1.6
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
245
2572
0.94
0.36
2.6
3.6
ph
7.4
7.4
0.29
55
504
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
5
76
0.66
0.35
1.0
1.1
—
1.7
—
0
6
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
9
122
0.74
0.35
1.1
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
125
0.72
0.35
1.4
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
43
1.40
0.35
1.2
3.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
850
8357
1.05
0.34
2.7
2.9
u/l
42.3
40.4
0.14
818
8009
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
10
133
0.75
0.33
2.8
2.6
u/ml
3.4
100.6
—
10
119
(3029396) Erythrocyte agglutination [Presence] in Blood
6
46
1.31
0.33
1.8
3.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
24
285
0.84
0.33
1.3
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
105
1129
0.92
0.31
1.6
2.3
%
25.8
24.5
0.39
86
977
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
52
1.35
0.31
1.0
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
99
0.71
0.30
2.4
1.8
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
100
0.70
0.30
1.0
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
72
658
1.10
0.30
2.7
2.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
17
207
0.82
0.30
1.0
1.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
479
4919
0.96
0.30
5.2
5.9
%
0.7
0.7
0.39
463
4640
(3000494) Fungus identified in Specimen by Culture
115
1229
0.93
0.30
1.6
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
55
608
0.90
0.29
1.4
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
82
888
0.92
0.29
1.8
1.7
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
8
108
0.74
0.29
1.1
2.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
110
0.73
0.29
1.0
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
147
1389
1.07
0.28
1.2
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
183
1745
1.06
0.27
2.4
2.3
mosm/kgh2o
560.2
542.8
0.47
154
1501
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
242
2326
1.05
0.26
1.9
2.0
mg/l
2.7
2.7
0.06
219
2025
(3021879) Hepatitis B virus core Ab [Presence] in Serum
102
1089
0.93
0.26
1.7
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
25
289
0.86
0.26
1.4
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
639
6269
1.04
0.26
7.3
8.7
e9/l
3.7
4.0
2.90
597
5539
(3015183) Erythrocyte sedimentation rate
12
95
1.27
0.26
1.3
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
12
95
1.27
0.26
1.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
73
0.68
0.26
2.4
1.7
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
72
1.25
0.25
1.3
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
18
213
0.84
0.25
1.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
17
202
0.84
0.25
1.2
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
13
105
1.24
0.25
1.2
1.7
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
16
191
0.84
0.24
1.4
1.8
g/l
0.6
0.8
0.65
11
142
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
39
350
1.12
0.24
1.4
1.9
%
91.4
93.9
0.40
34
322
(3025018) Bordetella pertussis Ab [Titer] in Serum
10
78
1.28
0.24
1.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
83
0.72
0.24
1.5
1.4
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
15
124
1.21
0.24
3.4
1.4
mu/l
98.1
41.5
0.87
15
114
(3021960) Folate [Moles/volume] in Serum or Plasma
176
1838
0.95
0.23
1.3
1.4
nmol/l
22.0
21.0
0.41
162
1628
(40768804) Tissue Pathology biopsy report
458
4476
1.04
0.23
1.8
1.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
121
1146
1.06
0.23
2.0
1.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
136
0.81
0.23
1.0
1.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
517
5276
0.97
0.23
5.1
5.6
%
55.6
56.4
1.03
499
5009
(3002030) Lymphocytes/100 leukocytes in Blood
523
5336
0.97
0.23
5.2
5.8
%
30.4
29.4
1.66
506
5056
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
93
0.75
0.22
1.0
2.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
42
381
1.11
0.22
1.5
2.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
246
2378
1.04
0.22
3.7
3.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
43
472
0.91
0.22
1.8
1.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
51
468
1.09
0.22
1.3
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
41
1.22
0.22
1.4
2.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
41
1.22
0.22
1.2
1.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
125
1314
0.95
0.22
1.8
2.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
42
1.19
0.21
3.0
1.9
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
0.4
—
0
5
(3032057) Clostridioides difficile [Presence] in Stool
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.7
—
15.1
—
0
10
(36660697) Celiac disease serology panel - Serum
98
1037
0.94
0.21
1.1
1.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
13
156
0.83
0.21
1.2
1.4
—
20.4
—
0
8
(3006315) Basophils [#/volume] in Blood
557
5470
1.03
0.21
5.3
5.8
e9/l
0.0
0.0
0.50
530
4839
(3016502) Oxygen saturation in Arterial blood
77
721
1.07
0.21
3.1
10.1
%
96.7
96.4
0.20
72
698
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
7.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
14
166
0.84
0.20
2.3
2.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
14
117
1.20
0.20
1.8
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
60
645
0.93
0.20
1.3
1.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
16
136
1.18
0.20
1.5
1.5
—
13.0
—
0
25
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
13
108
1.21
0.20
1.0
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
41
448
0.91
0.20
1.4
2.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
115
0.78
0.20
1.1
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
82
869
0.94
0.19
1.8
1.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
18
207
0.87
0.19
1.1
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
14
118
1.19
0.19
2.0
2.1
—
—
—
0
0
(4211845)
6
52
1.15
0.19
1.5
2.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
32
353
0.90
0.18
1.5
3.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
970
9780
0.97
0.18
4.3
4.4
mmol/mol
37.7
38.3
0.59
928
9286
(3017315) Amylase [Enzymatic activity/volume] in Urine
7
58
1.21
0.18
1.1
1.2
u/l
148.0
456.9
—
7
51
(3037121) Protein [Mass/volume] in Urine
29
321
0.90
0.18
2.0
3.7
g/l
0.1
0.2
—
10
133
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
25
223
1.12
0.18
1.0
1.0
u/ml
0.0
0.4
—
5
54
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
59
1.19
0.18
1.4
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
16
138
1.16
0.17
1.3
1.2
—
—
—
0
0
(3036603) Volume of Urine
5
67
0.75
0.17
1.4
1.6
ml
2081.8
2120.9
—
5
11
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
23
257
0.89
0.17
1.5
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
71
1.13
0.16
1.5
2.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
266
2595
1.03
0.16
1.8
1.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
151
0.86
0.15
1.2
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
15
172
0.87
0.15
1.9
2.1
g/l
129.5
134.4
—
10
129
(3038026) Centromere Ab [Units/volume] in Serum
6
77
0.78
0.15
1.3
1.2
—
90.0
—
0
5
(40768441) Liver Pathology biopsy report
6
79
0.76
0.15
1.2
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
9
78
1.15
0.15
1.2
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
78
1.15
0.15
1.6
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
79
1.14
0.15
1.2
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
34
313
1.09
0.15
2.0
2.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
41
381
1.08
0.15
1.3
1.3
—
—
—
0
0
(44806118)
11
129
0.85
0.14
1.4
1.6
—
—
—
0
0
(44790049)
11
129
0.85
0.14
1.4
1.6
—
—
—
0
0
(44790047)
11
129
0.85
0.14
1.4
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
11
129
0.85
0.14
2.2
1.5
—
—
—
0
0
(44790048)
11
129
0.85
0.14
1.4
1.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
552
5447
1.02
0.14
5.3
5.8
e9/l
0.5
0.5
1.05
527
4823
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
58
614
0.94
0.14
1.5
1.7
mg/l
2.6
4.5
0.84
39
418
(3048929) Epstein Barr virus Ab [Presence] in Serum
43
460
0.93
0.14
1.3
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
18
160
1.13
0.14
2.1
2.0
%
16.6
17.0
—
7
75
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
22
243
0.90
0.14
1.3
1.3
—
22.5
—
0
5
(4062490)
11
128
0.86
0.13
1.5
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
443
4364
1.02
0.13
2.0
2.2
nmol/l
77.6
74.6
1.58
424
4059
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
79
826
0.95
0.13
2.3
2.3
au/ml
21.5
23.1
—
9
64
(3008898) HLA-B27 [Presence]
64
608
1.06
0.13
1.0
1.1
—
—
—
0
0
(3000492) Spirometry study
128
1239
1.04
0.13
1.3
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
20
221
0.90
0.12
3.7
4.2
%
55.6
57.1
0.23
20
221
(3000570) Elastase.pancreatic [Mass/mass] in Stool
31
287
1.08
0.12
1.3
1.4
ug/g
287.3
314.5
0.27
16
155
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
38
406
0.93
0.12
3.2
12.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
310
3156
0.98
0.12
2.1
2.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
17
152
1.12
0.12
1.8
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
19
210
0.90
0.12
2.6
2.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
115
1113
1.04
0.12
1.4
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
172
1.11
0.11
1.7
1.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
125
1288
0.97
0.11
1.6
2.0
s
28.0
29.4
3.59
119
1256
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
19
209
0.91
0.11
1.2
1.2
u/ml
3.2
5.8
—
5
82
(3034274) Bile acid [Moles/volume] in Serum --fasting
27
250
1.08
0.11
2.4
2.2
umol/l
6.6
4.5
0.44
18
183
(3009445) Proteinase 3 Ab [Units/volume] in Serum
37
393
0.94
0.10
1.5
1.5
—
7.3
—
0
13
(3019832) Treponema pallidum Ab [Presence] in Serum
198
1938
1.03
0.10
1.8
1.7
—
—
—
0
0
(4306422)
19
208
0.91
0.10
1.2
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
44
1.14
0.10
2.8
1.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
269
2646
1.02
0.10
1.9
2.1
u/l
143.8
179.7
0.69
253
2517
(3006462) Nitrate [Presence] in Urine
5
45
1.11
0.09
1.6
2.6
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
15
135
1.11
0.09
1.1
1.6
—
17.8
—
0
5
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
15
135
1.11
0.09
1.1
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
157
1606
0.97
0.09
2.2
3.0
ng/l
214.7
476.9
0.83
75
958
(1616796) Gas panel - Central venous blood
19
174
1.09
0.09
2.1
2.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
24
258
0.93
0.09
1.6
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
73
756
0.96
0.09
1.0
1.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
18
196
0.92
0.09
2.8
2.3
ug/min
232.0
147.0
0.14
12
129
(3036071) Salmonella sp Ab [Titer] in Serum
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
23
247
0.93
0.08
1.5
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
19
206
0.92
0.08
1.2
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
57
1.05
0.08
1.0
1.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
123
1260
0.97
0.08
1.6
2.2
g/l
2.6
2.4
2.14
112
1174
(3020876) Protein [Mass/time] in 24 hour Urine
5
60
0.83
0.08
1.4
2.1
—
1.6
—
0
8
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
63
0.79
0.08
3.0
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1107
11106
0.98
0.08
9.4
11.1
%
40.0
40.5
0.98
866
9128
(3044290) Cell count panel - Cerebral spinal fluid
22
236
0.93
0.08
1.0
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
71
0.84
0.07
1.0
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
20
215
0.93
0.07
3.3
3.8
e9/l
3.8
4.2
0.40
20
215
(4024509)
6
72
0.83
0.07
1.5
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
271
2746
0.98
0.07
2.2
2.7
e6/l
20.7
53.8
1.99
224
2074
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
73
0.82
0.07
1.2
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
28
264
1.06
0.07
1.1
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
82
0.85
0.07
1.0
1.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
84
1.07
0.07
1.3
2.0
pg
32.8
32.5
—
9
84
(40768795) Lymph node Pathology biopsy report
9
85
1.06
0.07
1.6
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
134
1314
1.02
0.07
1.9
1.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
15
163
0.92
0.07
1.3
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
214
0.93
0.07
1.0
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
339
3425
0.99
0.07
2.4
3.1
e6/l
50.5
72.0
0.37
241
2269
(42529406) Shigella sp [Presence] in Stool by Culture
32
336
0.95
0.07
1.1
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
93
0.86
0.06
1.1
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
93
0.86
0.06
1.3
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
142
0.91
0.06
1.6
1.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
9
104
0.86
0.06
2.3
2.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
16
148
1.08
0.06
2.0
1.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
27
256
1.06
0.06
1.1
1.3
mmol/l
3.8
3.7
0.18
27
238
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
47
486
0.97
0.05
1.6
3.1
kpa
4.9
5.2
1.34
42
457
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
144
1463
0.98
0.05
2.2
1.9
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
25
238
1.05
0.05
1.2
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
238
2404
0.99
0.05
1.8
2.0
—
—
—
0
0
(3036489) Thrombin time
41
397
1.03
0.04
1.3
1.9
s
20.3
20.9
0.65
29
340
(3045414) Leukocytes [Presence] in Urine
48
493
0.97
0.04
1.6
1.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
67
656
1.02
0.04
2.5
3.3
mmol/l
2.2
1.9
0.35
50
528
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
17
180
0.94
0.04
2.3
2.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
53
517
1.03
0.04
1.9
2.7
e9/l
74.4
74.9
0.03
39
373
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
121
1.08
0.03
1.8
1.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
32
331
0.97
0.03
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
32
331
0.97
0.03
1.1
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
14
149
0.94
0.03
1.1
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
151
1.06
0.03
1.1
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
256
2577
0.99
0.03
1.8
2.3
umol/l
1288.2
4037.1
1.57
238
2311
(3022948) Iron [Moles/volume] in Serum or Plasma
140
1386
1.01
0.03
1.6
2.2
umol/l
15.8
14.6
1.08
126
1290
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
23
239
0.96
0.02
1.3
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
75
760
0.99
0.02
1.2
1.3
au/ml
40.5
36.5
—
5
38
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
117
0.94
0.01
1.1
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
127
0.94
0.01
1.2
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
12
127
0.94
0.01
1.2
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
84
831
1.01
0.01
3.1
9.3
mmol/l
1.2
1.1
0.13
51
642
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
110
1092
1.01
0.01
2.6
2.5
ug/l
0.8
0.7
0.56
52
583
(3011288) Drugs identified in Urine by Screen method
50
507
0.99
0.01
1.7
2.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
386
3852
1.00
0.01
4.0
4.6
g/l
37.2
36.9
0.84
364
3608
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
24
234
1.03
0.00
1.1
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
84
834
1.01
0.00
15.1
12.5
inr
1.2
1.2
0.12
26
138
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
11
114
0.96
0.00
1.5
1.5
g/l
1.0
1.0
0.15
11
114
(3021788) Differential panel - Synovial fluid
16
164
0.98
0.00
2.2
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
13
128
1.02
0.00
1.2
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
13
128
1.02
0.00
1.2
1.3
—
—
—
0
0
(4027681)
10
99
1.01
0.00
1.2
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
13
129
1.01
0.00
1.2
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
22
221
1.00
0.00
1.3
1.4
u/ml
122.1
100.6
—
8
44
(3025468) Yersinia sp identified in Specimen by Organism specific culture
13
127
1.02
0.00
1.2
1.3
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
15
153
0.98
0.00
1.1
1.1
g/l
1.4
1.5
0.04
15
139
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
30
303
0.99
0.00
1.3
1.5
nmol/l
0.5
0.4
0.26
22
244
(3017732) Neutrophils [#/volume] in Blood
82
817
1.00
0.00
2.0
2.3
e9/l
3.7
4.0
0.93
76
707
(3004716) Salmonella sp identified in Stool by Organism specific culture
77
775
0.99
0.00
1.6
1.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
21
215
0.98
0.00
1.1
2.9
nmol/l
0.7
0.9
0.43
16
183
(3016650) Hepatitis A virus Ab [Presence] in Serum
21
205
1.02
0.00
1.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
13
125
1.04
0.00
1.3
1.1
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
5
54
0.93
0.00
1.2
1.1
—
10.9
—
0
11
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
80
1.00
0.00
1.1
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
49
1.02
0.00
2.0
1.8
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
9
97
0.93
0.00
1.0
1.1
mg/l
266.7
285.9
—
9
89
(21494434) Karyotype in Bone marrow
5
54
0.93
0.00
1.0
1.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
9
95
0.95
0.00
4.7
3.4
u/ml
24.6
55.8
—
9
95
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
7
79
0.89
0.00
1.0
1.0
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
6
65
0.92
0.00
1.0
1.5
%
—
71.8
—
0
8
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
89
1.01
0.00
1.1
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
9
91
0.99
0.00
1.0
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
7
79
0.89
0.00
1.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
79
790
1.00
0.00
1.9
2.2
ml/min/173m2
78.1
77.1
0.09
35
300
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
9
91
0.99
0.00
1.0
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
13
130
1.00
0.00
1.2
1.3
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
6.0
—
0
8
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
7
73
0.96
0.00
1.1
1.6
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.7
—
4.3
—
0
7
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
55
0.91
0.00
1.6
1.4
nmol/l
122.0
145.9
—
5
55
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
90
1.00
0.00
1.0
1.2
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
8
0.00
0.00
0.0
2.9
—
8.7
—
0
8
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
90
1.00
0.00
1.0
1.2
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.6
—
233.8
—
0
5
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
7
0.00
0.00
0.0
1.7
—
2.4
—
0
7
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
50
1.00
0.00
2.8
1.5
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.1
—
16.4
—
0
9
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
13
130
1.00
0.00
1.2
1.3
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.6
—
347.6
—
0
9
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
9
91
0.99
0.00
1.0
1.2
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
180.7
—
0
9
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
9
90
1.00
0.00
1.0
1.2
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
91
0.99
0.00
1.6
1.5
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: OPER_BSSRO – Bilateral sagittal split ramus osteotomy operation

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).